Quick Summary
Covering the latest research from top Wall Street investment banks

Bernstein: Chemical pricing may rise structurally, but "middle-layer" companies face pressure in 2H

Institution
Bernstein
Date
2026-07-15
Authors
James Hooper, Abdessamad Raghibi, Ph.D., Sebastien Afoy
Company
-
Ticker
-
Industry
Chemicals
Rating
Outperform for Linde, Air Products, BASF, Air Liquide, Fertiglobe, PPG and Syensqo; Market-Perform for Akzo Nobel, Arkema, SABIC, Borouge, Clariant and Solvay
NeutralLow confidenceThe report maintains the existing rating framework, favors industrial gases and selected leaders in commodity/specialty chemicals, while warning that companies caught between commodity and specialty positioning may come under pressure amid weak demand.
AuthorsJames Hooper, Abdessamad Raghibi, Ph.D., Sebastien Afoy
CoverageUnited States、Europe
Asset classesEquity
Business segmentsindustrial gases、specialty chemicals、commodity chemicals、petrochemicals、fertilisers、paints and coatings、industrial chemicals、soda ash、catalysts、agricultural inputs
Research firm divisions/subsidiariesBernstein(Other)

AI summary card

Bernstein: Chemical pricing may rise structurally, but "middle-layer" companies face pressure in 2H

The report argues that financial markets underestimate the persistence of supply disruptions in chemicals. Industrial gases, BASF, and selected fertilizer/paint/industrial chemical companies offer better risk-reward, while mid-cap and small-cap European companies lacking clear specialty or commodity characteristics are more vulnerable.

Ratings unchanged: Linde, Air Products, BASF, Air Liquide, Fertiglobe, PPG, and Syensqo are rated Outperform; Akzo Nobel, Arkema, SABIC, Borouge, Clariant, and Solvay are rated Market-Perform.
ChemicalsIndustrial gasesCommodity chemicalsSpecialty chemicalsIran-related disruptionsEuropean regulation2027 scenario analysis
  • Bernstein believes that inventory release and the short-term pullback in oil prices are insufficient to change the supply-constrained backdrop, and it raises long-term PE and PP price assumptions by about 5%-15%.
  • Top picks remain industrial gas companies Linde and Air Products, with BASF upgraded to the top European pick; the firm is also positive on Fertiglobe, PPG, and Syensqo.
  • The report is more cautious on Clariant and Solvay, but does not downgrade them to Underperform; the core concerns are the trajectory of Catalysts and the soda ash supply-demand environment, respectively.
  • The 2027 scenario analysis shows average upside across the covered group of about 38% and 20% under the U.S.-led recovery and U.S.-only recovery scenarios; the stable scenario implies about +3%, and the deterioration scenario about -20%.

Report interpretation

Overview

This is an industry/company research report by Bernstein on its global chemicals coverage universe. The core view is that the market is interpreting the decline in commodity chemical prices, inventory release, and the partial recovery of transport through the Strait of Hormuz too optimistically; the research team still believes that the capacity, logistics, and energy disruptions stemming from Iran-related conflict are not over, and that chemical prices have structurally shifted higher versus pre-war levels.

Core views

The report emphasizes pricing power as the key differentiating variable in the current environment. True specialty chemical companies are better able to pass through costs; some commodity chemical applications have relatively inelastic demand and may also benefit from supply disruptions and higher prices. But companies positioned between commodities and specialties lack strong pricing power and are also less able to benefit directly from tight supply, potentially forcing difficult trade-offs between price and volume in 2H26. Industrial gases remain the preferred subsector, while BASF is elevated to the top European pick due to what is seen as an excessive share price pullback and agricultural catalysts in 2H26.

Analysis framework

The report combines chemical prices, oil and gas and inventories, Strait of Hormuz transportation, regional supply and demand, agriculture and fertilizer seasonality, consumer confidence, European industrial policy, and covered-company valuations to update its 2027 cyclical recovery/macroeconomic scenario analysis, and uses consistent assumptions to compare potential share price returns across covered companies under different macro scenarios.

Methodology notes

  • scenario_analysis2027 cyclical recovery/macroeconomic scenario framework

    Four-scenario share price risk-reward analysis

    The report sets four scenarios—U.S.-led cyclical recovery, U.S.-only recovery, stable, and deterioration—and applies consistent assumptions on revenue, EBITDA/EPS, regional exposure, commodity chemical operating leverage, and valuation multiples to improve comparability across companies and avoid selective assumptions.

  • Valuation methodsRelative valuation and historical percentile valuation

    Deriving scenario prices using current multiples, 5-year median, 75th percentile, or 25th percentile valuation

    In recovery scenarios, it uses the higher of current multiples and historically higher percentiles; in the stable scenario, it uses the 5-year median; in the deterioration scenario, it uses the lower of current multiples and historically lower percentiles.

  • industry_cycleStructural high-price view on commodity chemicals

    Supply disruptions, inventory release, and energy prices jointly determine long-term PE/PP prices

    The research team believes that inventory release in China cannot sustainably replace constrained capacity, that oil prices resume rising after conflict-related disruptions, and that logistics are still not fully normalized, so it maintains the view that commodity chemical prices are structurally higher than pre-war levels.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • Linde
    One of the preferred industrial gas companies, rated Outperform
    Strengths
    The industrial gas subsector is the report's top preference, with strong business quality and pricing resilience.
    Weaknesses
    High valuation may limit short-term upside.
    Comparison
    Compared with Air Liquide, the report prefers Linde and Air Products.
    Risks
    Macro recovery falling short of expectations, weaker industrial demand, or valuation compression.
  • Air Products
    One of the preferred industrial gas companies, rated Outperform
    Strengths
    Benefits from the resilience of the industrial gas subsector and the report's preferred ranking.
    Weaknesses
    Still faces macro demand and project execution risks.
    Comparison
    Ranked alongside Linde as a top U.S. industrial gas pick.
    Risks
    Earnings growth missing expectations, energy cost pressure, or capital expenditure pressure.
  • BASF
    Top European pick, rated Outperform
    Strengths
    The share price pullback is seen as excessive, there are agriculture-related catalysts in 2H26, and it may benefit from some anti-dumping investigations.
    Weaknesses
    Large German manufacturing footprint means European energy and industrial policy constraints remain.
    Comparison
    Its ranking within European coverage has risen.
    Risks
    Weak European demand, insufficient regulatory support, and falling commodity chemical prices.
  • Air Liquide
    Rated Outperform but less preferred than Linde and Air Products
    Strengths
    High-quality industrial gas business.
    Weaknesses
    The report worries that market consensus is too optimistic in modeling accelerating comparable growth in 2H26, while the stock is at historical highs.
    Comparison
    Less preferred than Linde and Air Products among industrial gas names.
    Risks
    Growth disappointment under a high valuation.
  • Fertiglobe
    Preferred fertilizer name, rated Outperform
    Strengths
    Weak nitrogen fertilizer prices are viewed as seasonal rather than structural, and higher crop prices may support fertilizer demand.
    Weaknesses
    Short-term disruptions from China's urea exports and seasonal off-season weakness.
    Comparison
    Explicitly favored within the fertilizer space.
    Risks
    Weaker fertilizer demand, increased export supply, and changes in energy and transport disruptions.
  • PPG
    Preferred name in paints and coatings, rated Outperform
    Strengths
    The report expresses a positive view on Paints & Coatings.
    Weaknesses
    End demand is linked to consumers and industrial activity, creating price/volume elasticity risk.
    Comparison
    The report is more positive versus Akzo Nobel.
    Risks
    Weaker consumer demand, raw material cost pressure, and insufficient price pass-through.
  • Syensqo
    Favored in industrial chemicals but also listed as one of the "middle-layer" risks, rated Outperform
    Strengths
    The report still lists it as one of the preferred names.
    Weaknesses
    Among smaller European market-cap coverage, it may be affected by the "middle-layer" scenario.
    Comparison
    Listed alongside Arkema, Clariant, and Solvay in the risk group, but still rated Outperform.
    Risks
    Demand deterioration, insufficient pricing power, and weak European macro conditions.
  • Clariant
    Rated Market-Perform, with a more cautious view
    Strengths
    Still not downgraded to Underperform.
    Weaknesses
    The report is particularly concerned about the trajectory of the Catalysts business.
    Comparison
    Weaker risk-reward than the preferred names.
    Risks
    Deterioration in the catalysts business, weak demand, and insufficient price pass-through.
  • Solvay
    Rated Market-Perform, with a more cautious view
    Strengths
    Valuation and certain businesses may provide some support.
    Weaknesses
    The report remains negative on soda ash demand and supply conditions.
    Comparison
    Along with Clariant, it is one of the more cautious calls.
    Risks
    Deteriorating soda ash supply-demand, weak European demand, and earnings downgrades.

Key data

  • Long-term PE/PP price assumptionsRaised by about 5%-15%The report says it reaffirms the structurally higher price view and reflects it in long-term PE and PP price forecasts.
  • U.S.-led cyclical recovery scenarioAverage upside across coverage of about 38%From the report's updated 2027 cyclical recovery scenario analysis.
  • U.S.-only recovery scenarioAverage upside across coverage of about 20%The recovery is narrower in scope, so valuation and earnings support are weaker than in the U.S.-led recovery scenario.
  • Stable scenarioAbout +3% returnAssumes current 2027E Bloomberg consensus is broadly correct and uses 5-year median valuation multiples.
  • Deterioration scenarioAbout -20% downsideAssumes consumers weaken demand under inflation pressure, leading to earnings downgrades.
  • China urea export quotaAbout 3.3mt in Jun-Oct 2026The report views this as below the usual level of about 5mt, adding short-term noise but not constituting a structural supply glut.

Impact & implications

The investment implication is that the chemicals sector should not be simplistically divided into specialty being better than commodity. In the current environment, the most attractive areas are specialty chemical companies with strong pricing power, commodity chemical companies supported by supply constraints, and leading industrial gas companies; companies positioned between the two, especially those whose end demand is tied to consumer health, may come under pressure in 2H26. European policy support is seen as insufficient to materially improve financial performance over this decade, making stock selection more important than simply betting on regulatory rescue.

Risks

  • Consumers may cut demand under high inflation and high price pressure, causing chemical companies' volumes to decline or forcing price cuts.
  • Inventory release may be misread by the market as supply recovery, but if inventories cannot be replenished sustainably, price volatility could increase.
  • If transport through the Strait of Hormuz and Middle East capacity disruptions ease quickly, support for commodity chemical prices could weaken.
  • European regulatory and industrial policy support may be insufficient to improve chemicals companies' financial performance over this decade.
  • Companies positioned between commodities and specialties may lack sufficient pricing power, exposing pressure in 2H26 earnings.

What to watch

  • Whether vessel traffic through the Strait of Hormuz returns to normal levels, especially for non-liquid cargo transport.
  • Changes in China's PE inventories, imports, exports, and operating rates to assess whether inventory monetization is nearing its end.
  • The impact of changes in oil prices, natural gas prices, and ethane cost advantages on ethylene and downstream PE/PP prices.
  • Whether 2H26 guidance from chemical companies is revised upward, and whether the magnitude of revisions is below sell-side consensus.
  • The actual execution strength of European anti-dumping investigations, ETS reform, the Critical Chemicals Alliance, and the Industrial Accelerator Act.
  • Crop prices, fertilizer pre-buying, urea export quotas, and Northern Hemisphere autumn restocking demand.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins